Medicare Enrolled

Dr. Amber Mahal, M.D.

Family Medicine · Fresno, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
7710 N FRESNO ST # 102, Fresno, CA 93720
5594379100
In practice since 2008 (17 years)
NPI: 1134370901 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mahal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mahal? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mahal

Dr. Amber Mahal is a family medicine specialist in Fresno, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Mahal performed 1,432 Medicare services across 866 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mahal received a total of $6,955 from 50 pharmaceutical and/or device companies across 400 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mahal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 15% volume in CA $6,955 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,432
Medicare services
Top 15% in CA for family medicine
866
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~84 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
846 $87 $175
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
189 $87 $138
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
103 $132 $162
Pelvic and clinical breast exam for cancer screening
A physical examination of the pelvis and breasts to screen for cervical or vaginal cancer. This procedure involves a clinical assessment performed by a healthcare provider.
68 $40 $60
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
55 $3 $5
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
42 $10 $40
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
31 $31 $40
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
26 $72 $80
Pneumonia vaccine administration
This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider.
22 $31 $40
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
21 $89 $240
Pneumococcal conjugate vaccine (PCV20)
An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria.
18 $280 $292
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
11 $62 $135
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,955
Total received (2018-2024)
Avg $994/year across 7 years
Top 6% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
400
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,955 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,000
2023
$1,075
2022
$765
2021
$819
2020
$399
2019
$1,729
2018
$1,168

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$225
Lilly USA, LLC
$150
AstraZeneca Pharmaceuticals LP
$133
Astellas Pharma US Inc
$89
PFIZER INC.
$82
Abbott Laboratories
$67
Amgen Inc.
$57
Esperion Therapeutics, Inc.
$40
Phathom Pharmaceuticals, Inc.
$39
Otsuka America Pharmaceutical, Inc.
$37
GlaxoSmithKline, LLC.
$28
Dexcom, Inc.
$23
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$16
Kowa Pharmaceuticals America, Inc.
$14
Top 3 companies account for 50.8% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$777
AstraZeneca Pharmaceuticals LP
$674
Amgen Inc.
$577
Lilly USA, LLC
$543
Otsuka America Pharmaceutical, Inc.
$406
PFIZER INC.
$403
Amarin Pharma Inc.
$313
Takeda Pharmaceuticals U.S.A., Inc.
$288
AbbVie, Inc.
$286
AbbVie Inc.
$224
Novo Nordisk Inc
$197
Boehringer Ingelheim Pharmaceuticals, Inc.
$175
Novartis Pharmaceuticals Corporation
$173
GlaxoSmithKline, LLC.
$172
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$162
Gilead Sciences, Inc.
$136
Teva Pharmaceuticals USA, Inc.
$121
Abbott Laboratories
$118
Astellas Pharma US Inc
$118
Merck Sharp & Dohme Corporation
$108
Janssen Pharmaceuticals, Inc
$88
Kowa Pharmaceuticals America, Inc.
$81
ARBOR PHARMACEUTICALS, INC.
$67
Horizon Therapeutics plc
$61
Shire North American Group Inc
$53
IDORSIA PHARMACEUTICALS US INC
$51
Dexcom, Inc.
$47
IBSA Pharma Inc.
$45
Allergan Inc.
$43
Esperion Therapeutics, Inc.
$40
Phathom Pharmaceuticals, Inc.
$39
ViiV Healthcare Company
$36
Philips Electronics North America Corporation
$31
Bayer Healthcare Pharmaceuticals Inc.
$23
Ultragenyx Pharmaceutical Inc.
$22
ITI, Inc.
$22
Antares Pharma, Inc.
$21
GENZYME CORPORATION
$20
Synergy Pharmaceuticals Inc
$19
Hologic, LLC
$18
Arbor Pharmaceuticals, Inc.
$18
IRONWOOD PHARMACEUTICALS, INC
$18
Biohaven Pharmaceuticals, Inc.
$17
Allergan, Inc.
$17
Oxford Immunotec USA Inc
$17
SANOFI PASTEUR INC.
$15
Eisai Inc.
$15
VistaPharm, Inc.
$15
Azurity Pharmaceuticals, Inc.
$13
Adlon Therapeutics L.P.
$12
Top 3 companies account for 29.2% of all-time payments
Associated products mentioned in payments ›
ADHANSIA XR · AIRSUPRA · AJOVY · APRETUDE · Aimovig · AirDuo Digihaler · Amitiza · Androgel · Aptima Trichomonas · BREZTRI · BRILINTA · CAPLYTA · CHANTIX · COMIRNATY · DUPIXENT · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · Edarbi · Edarbyclor · FARXIGA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · LYRICA · Licart · Linzess · Livalo · MOUNJARO · MYDAYIS · NEXLETOL · NURTEC ODT · Otezla · Otrexup · Ozempic · PENNSAID · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · QULIPTA · QUVIVIQ · REXULTI · Repatha · SEGLENTIS · SHINGRIX · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Synthroid · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TSPOT TB TEST · Thyquidity · Tirosint · Tresiba · Trilogy 100 · Trintellix · Trulance · UBRELVY · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · Vesicare · Victoza · XARELTO · XIFAXAN · ZORYVE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for family medicine in CA.

Looking for a family medicine specialist in Fresno?
Compare family medicine physicians in the Fresno area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
359
Per 100K population
35.5
County median income
$71,434
Nearest hospital
SAINT AGNES MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mahal is a clinical cardiology specialist, with above-average Medicare volume (top 15% in CA), with low-engagement industry engagement in the top 6% of CA peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mahal experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mahal performed 846 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mahal receive payments from pharmaceutical companies?
Yes. Dr. Mahal received a total of $6,955 from 50 companies across 400 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mahal's costs compare to other family medicine physicians in Fresno?
Dr. Mahal's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mahal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →